Global Psoriatic Arthritis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Psoriatic Arthritis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID : 281645
Published On: Mar, 2022
Pages: 156
Pharmaceuticals and Healthcare

Buy @ $3500

The Psoriatic Arthritis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Psoriatic Arthritis Therapeutics market size is estimated to be worth US$ 6585.3 million in 2021 and is forecast to a readjusted size of USD 11710 million by 2028 with a CAGR of 8.6% during review period. Hospitals accounting for % of the Psoriatic Arthritis Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nonsteroidal Anti-Inflammatory Drug segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Psoriatic Arthritis Therapeutics include Pfizer, Bayer, Novartis, Abbott Laboratories, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Psoriatic Arthritis Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Nonsteroidal Anti-Inflammatory Drug

Disease-Modifying Antirheumatic Drug

Biologic Drug

Enzyme Inhibitor

Market segment by Application, can be divided into

Hospitals

Clinics

Research Labs

Market segment by players, this report covers

Pfizer

Bayer

Novartis

Abbott Laboratories

Sanofi

Bristol-Myers Squibb

Janssen Biotech

Amgen

UCB

AbbVie

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Psoriatic Arthritis Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Psoriatic Arthritis Therapeutics, with revenue, gross margin and global market share of Psoriatic Arthritis Therapeutics from 2019 to 2022.

Chapter 3, the Psoriatic Arthritis Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Psoriatic Arthritis Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Psoriatic Arthritis Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Psoriatic Arthritis Therapeutics

1.2 Classification of Psoriatic Arthritis Therapeutics by Type

1.2.1 Overview: Global Psoriatic Arthritis Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type in 2021

1.2.3 Nonsteroidal Anti-Inflammatory Drug

1.2.4 Disease-Modifying Antirheumatic Drug

1.2.5 Biologic Drug

1.2.6 Enzyme Inhibitor

1.3 Global Psoriatic Arthritis Therapeutics Market by Application

1.3.1 Overview: Global Psoriatic Arthritis Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Labs

1.4 Global Psoriatic Arthritis Therapeutics Market Size & Forecast

1.5 Global Psoriatic Arthritis Therapeutics Market Size and Forecast by Region

1.5.1 Global Psoriatic Arthritis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Psoriatic Arthritis Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Psoriatic Arthritis Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Psoriatic Arthritis Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Psoriatic Arthritis Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Psoriatic Arthritis Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Psoriatic Arthritis Therapeutics Market Drivers

1.6.2 Psoriatic Arthritis Therapeutics Market Restraints

1.6.3 Psoriatic Arthritis Therapeutics Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Psoriatic Arthritis Therapeutics Product and Solutions

2.1.4 Pfizer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Bayer

2.2.1 Bayer Details

2.2.2 Bayer Major Business

2.2.3 Bayer Psoriatic Arthritis Therapeutics Product and Solutions

2.2.4 Bayer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Bayer Recent Developments and Future Plans

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Psoriatic Arthritis Therapeutics Product and Solutions

2.3.4 Novartis Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Novartis Recent Developments and Future Plans

2.4 Abbott Laboratories

2.4.1 Abbott Laboratories Details

2.4.2 Abbott Laboratories Major Business

2.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Product and Solutions

2.4.4 Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Abbott Laboratories Recent Developments and Future Plans

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business

2.5.3 Sanofi Psoriatic Arthritis Therapeutics Product and Solutions

2.5.4 Sanofi Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Sanofi Recent Developments and Future Plans

2.6 Bristol-Myers Squibb

2.6.1 Bristol-Myers Squibb Details

2.6.2 Bristol-Myers Squibb Major Business

2.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product and Solutions

2.6.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.7 Janssen Biotech

2.7.1 Janssen Biotech Details

2.7.2 Janssen Biotech Major Business

2.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Product and Solutions

2.7.4 Janssen Biotech Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Janssen Biotech Recent Developments and Future Plans

2.8 Amgen

2.8.1 Amgen Details

2.8.2 Amgen Major Business

2.8.3 Amgen Psoriatic Arthritis Therapeutics Product and Solutions

2.8.4 Amgen Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Amgen Recent Developments and Future Plans

2.9 UCB

2.9.1 UCB Details

2.9.2 UCB Major Business

2.9.3 UCB Psoriatic Arthritis Therapeutics Product and Solutions

2.9.4 UCB Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 UCB Recent Developments and Future Plans

2.10 AbbVie

2.10.1 AbbVie Details

2.10.2 AbbVie Major Business

2.10.3 AbbVie Psoriatic Arthritis Therapeutics Product and Solutions

2.10.4 AbbVie Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 AbbVie Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Psoriatic Arthritis Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Psoriatic Arthritis Therapeutics Players Market Share in 2021

3.2.2 Top 10 Psoriatic Arthritis Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Psoriatic Arthritis Therapeutics Players Head Office, Products and Services Provided

3.4 Psoriatic Arthritis Therapeutics Mergers & Acquisitions

3.5 Psoriatic Arthritis Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Psoriatic Arthritis Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Psoriatic Arthritis Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Psoriatic Arthritis Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Psoriatic Arthritis Therapeutics Revenue by Type (2017-2028)

6.2 North America Psoriatic Arthritis Therapeutics Revenue by Application (2017-2028)

6.3 North America Psoriatic Arthritis Therapeutics Market Size by Country

6.3.1 North America Psoriatic Arthritis Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Psoriatic Arthritis Therapeutics Revenue by Type (2017-2028)

7.2 Europe Psoriatic Arthritis Therapeutics Revenue by Application (2017-2028)

7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Country

7.3.1 Europe Psoriatic Arthritis Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region

8.3.1 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Region (2017-2028)

8.3.2 China Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Psoriatic Arthritis Therapeutics Revenue by Type (2017-2028)

9.2 South America Psoriatic Arthritis Therapeutics Revenue by Application (2017-2028)

9.3 South America Psoriatic Arthritis Therapeutics Market Size by Country

9.3.1 South America Psoriatic Arthritis Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country

10.3.1 Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Psoriatic Arthritis Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Psoriatic Arthritis Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Psoriatic Arthritis Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Psoriatic Arthritis Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Psoriatic Arthritis Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Psoriatic Arthritis Therapeutics Product and Solutions

Table 9. Pfizer Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Bayer Corporate Information, Head Office, and Major Competitors

Table 11. Bayer Major Business

Table 12. Bayer Psoriatic Arthritis Therapeutics Product and Solutions

Table 13. Bayer Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Novartis Corporate Information, Head Office, and Major Competitors

Table 15. Novartis Major Business

Table 16. Novartis Psoriatic Arthritis Therapeutics Product and Solutions

Table 17. Novartis Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 19. Abbott Laboratories Major Business

Table 20. Abbott Laboratories Psoriatic Arthritis Therapeutics Product and Solutions

Table 21. Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Sanofi Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi Psoriatic Arthritis Therapeutics Product and Solutions

Table 25. Sanofi Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 27. Bristol-Myers Squibb Major Business

Table 28. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product and Solutions

Table 29. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Janssen Biotech Corporate Information, Head Office, and Major Competitors

Table 31. Janssen Biotech Major Business

Table 32. Janssen Biotech Psoriatic Arthritis Therapeutics Product and Solutions

Table 33. Janssen Biotech Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Amgen Corporate Information, Head Office, and Major Competitors

Table 35. Amgen Major Business

Table 36. Amgen Psoriatic Arthritis Therapeutics Product and Solutions

Table 37. Amgen Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. UCB Corporate Information, Head Office, and Major Competitors

Table 39. UCB Major Business

Table 40. UCB Psoriatic Arthritis Therapeutics Product and Solutions

Table 41. UCB Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. AbbVie Corporate Information, Head Office, and Major Competitors

Table 43. AbbVie Major Business

Table 44. AbbVie Psoriatic Arthritis Therapeutics Product and Solutions

Table 45. AbbVie Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Psoriatic Arthritis Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Psoriatic Arthritis Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Psoriatic Arthritis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Psoriatic Arthritis Therapeutics Players Head Office, Products and Services Provided

Table 50. Psoriatic Arthritis Therapeutics Mergers & Acquisitions in the Past Five Years

Table 51. Psoriatic Arthritis Therapeutics New Entrants and Expansion Plans

Table 52. Global Psoriatic Arthritis Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 53. Global Psoriatic Arthritis Therapeutics Revenue Share by Type (2017-2022)

Table 54. Global Psoriatic Arthritis Therapeutics Revenue Forecast by Type (2023-2028)

Table 55. Global Psoriatic Arthritis Therapeutics Revenue by Application (2017-2022)

Table 56. Global Psoriatic Arthritis Therapeutics Revenue Forecast by Application (2023-2028)

Table 57. North America Psoriatic Arthritis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Psoriatic Arthritis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Psoriatic Arthritis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Psoriatic Arthritis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Psoriatic Arthritis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Psoriatic Arthritis Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Psoriatic Arthritis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Psoriatic Arthritis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Psoriatic Arthritis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Psoriatic Arthritis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Psoriatic Arthritis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Psoriatic Arthritis Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Psoriatic Arthritis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Psoriatic Arthritis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Psoriatic Arthritis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Psoriatic Arthritis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Psoriatic Arthritis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Psoriatic Arthritis Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Psoriatic Arthritis Therapeutics Picture

Figure 2. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type in 2021

Figure 3. Nonsteroidal Anti-Inflammatory Drug

Figure 4. Disease-Modifying Antirheumatic Drug

Figure 5. Biologic Drug

Figure 6. Enzyme Inhibitor

Figure 7. Psoriatic Arthritis Therapeutics Revenue Market Share by Application in 2021

Figure 8. Hospitals Picture

Figure 9. Clinics Picture

Figure 10. Research Labs Picture

Figure 11. Global Psoriatic Arthritis Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Psoriatic Arthritis Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Region (2017-2028)

Figure 14. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Region in 2021

Figure 15. North America Psoriatic Arthritis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Psoriatic Arthritis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Psoriatic Arthritis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Psoriatic Arthritis Therapeutics Market Drivers

Figure 21. Psoriatic Arthritis Therapeutics Market Restraints

Figure 22. Psoriatic Arthritis Therapeutics Market Trends

Figure 23. Pfizer Recent Developments and Future Plans

Figure 24. Bayer Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. Abbott Laboratories Recent Developments and Future Plans

Figure 27. Sanofi Recent Developments and Future Plans

Figure 28. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 29. Janssen Biotech Recent Developments and Future Plans

Figure 30. Amgen Recent Developments and Future Plans

Figure 31. UCB Recent Developments and Future Plans

Figure 32. AbbVie Recent Developments and Future Plans

Figure 33. Global Psoriatic Arthritis Therapeutics Revenue Share by Players in 2021

Figure 34. Psoriatic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Psoriatic Arthritis Therapeutics Revenue Market Share in 2021

Figure 36. Global Top 10 Players Psoriatic Arthritis Therapeutics Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Psoriatic Arthritis Therapeutics Revenue Share by Type in 2021

Figure 39. Global Psoriatic Arthritis Therapeutics Market Share Forecast by Type (2023-2028)

Figure 40. Global Psoriatic Arthritis Therapeutics Revenue Share by Application in 2021

Figure 41. Global Psoriatic Arthritis Therapeutics Market Share Forecast by Application (2023-2028)

Figure 42. North America Psoriatic Arthritis Therapeutics Sales Market Share by Type (2017-2028)

Figure 43. North America Psoriatic Arthritis Therapeutics Sales Market Share by Application (2017-2028)

Figure 44. North America Psoriatic Arthritis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 45. United States Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Psoriatic Arthritis Therapeutics Sales Market Share by Type (2017-2028)

Figure 49. Europe Psoriatic Arthritis Therapeutics Sales Market Share by Application (2017-2028)

Figure 50. Europe Psoriatic Arthritis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 51. Germany Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Psoriatic Arthritis Therapeutics Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Psoriatic Arthritis Therapeutics Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue Market Share by Region (2017-2028)

Figure 59. China Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Psoriatic Arthritis Therapeutics Sales Market Share by Type (2017-2028)

Figure 66. South America Psoriatic Arthritis Therapeutics Sales Market Share by Application (2017-2028)

Figure 67. South America Psoriatic Arthritis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Psoriatic Arthritis Therapeutics Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Psoriatic Arthritis Therapeutics Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

License Type

Quick Contact

Our Clients

Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz